State of Wyoming’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $394K | Buy |
18,155
+5,508
| +44% | +$120K | 0.05% | 445 |
|
|
2025
Q1 | $307K | Sell |
12,647
-12,771
| -50% | -$310K | 0.04% | 540 |
|
|
2024
Q4 | $530K | Buy |
25,418
+2,199
| +9% | +$45.9K | 0.07% | 235 |
|
|
2024
Q3 | $462K | Buy |
23,219
+14,993
| +182% | +$298K | 0.07% | 222 |
|
|
2024
Q2 | $127K | Sell |
8,226
-2,269
| -22% | -$35.1K | 0.02% | 864 |
|
|
2024
Q1 | $167K | Buy |
10,495
+1,753
| +20% | +$27.9K | 0.03% | 713 |
|
|
2023
Q4 | $147K | Sell |
8,742
-874
| -9% | -$14.7K | 0.03% | 755 |
|
|
2023
Q3 | $112K | Sell |
9,616
-4,151
| -30% | -$48.5K | 0.02% | 786 |
|
|
2023
Q2 | $185K | Buy |
13,767
+4,249
| +45% | +$57.1K | 0.05% | 424 |
|
|
2023
Q1 | $158K | Sell |
9,518
-10,376
| -52% | -$172K | 0.05% | 495 |
|
|
2022
Q4 | $370K | Sell |
19,894
-7,460
| -27% | -$139K | 0.12% | 83 |
|
|
2022
Q3 | $351K | Buy |
27,354
+3,759
| +16% | +$48.2K | 0.17% | 61 |
|
|
2022
Q2 | $165K | Sell |
23,595
-5,261
| -18% | -$36.8K | 0.1% | 208 |
|
|
2022
Q1 | $239K | Sell |
28,856
-3,877
| -12% | -$32.1K | 0.12% | 133 |
|
|
2021
Q4 | $222K | Buy |
+32,733
| New | +$222K | 0.1% | 185 |
|